MYTEKA (Montelukast Sodium 4 mg, 5 mg & 10 mg) is an oral leukotriene receptor antagonist formulated to manage and prevent symptoms associated with asthma and allergic rhinitis in both pediatric and adult populations. Each tablet contains Montelukast Sodium, a medication that blocks leukotriene receptors in the lungs and nasal passages, thereby reducing inflammation, bronchoconstriction, and mucus production. MYTEKA is available in three dosages—4 mg, 5 mg, and 10 mg—to cater to different age groups and specific medical needs, ensuring effective and personalized respiratory care.
Key Features and Benefits:
- Effective Leukotriene Inhibition: Montelukast Sodium blocks leukotriene receptors, reducing inflammation, bronchoconstriction, and mucus production in the airways.
- Asthma Management: Helps prevent and control asthma symptoms, including wheezing, shortness of breath, and chest tightness, thereby improving lung function and overall respiratory health.
- Allergic Rhinitis Relief: Alleviates symptoms of seasonal and perennial allergic rhinitis, such as nasal congestion, sneezing, runny nose, and itchy eyes, enhancing daily comfort and productivity.
- Exercise-Induced Bronchoconstriction: Prevents bronchoconstriction triggered by physical activity, allowing individuals to engage in exercise with reduced respiratory discomfort.
- Flexible Dosage Options: Available in 4 mg, 5 mg, and 10 mg tablets, allowing for tailored dosing based on age, weight, and specific medical requirements.
- Once-Daily Dosing: Offers the convenience of once-daily administration, promoting better adherence to treatment regimens and simplifying medication schedules.
- Non-Sedating: Unlike some antihistamines, Montelukast does not typically cause drowsiness, allowing individuals to maintain their daily activities without impairment.
- Proven Efficacy: Supported by extensive clinical research, MYTEKA has demonstrated its effectiveness in managing chronic respiratory conditions, making it a trusted choice for healthcare providers and patients alike.
- Convenient Oral Administration: Tablets are easy to swallow and integrate seamlessly into daily medication regimens, ensuring adherence and consistent therapeutic outcomes.
Usage Instructions:
Dosage and Administration:
1. Montelukast Sodium 4 mg Tablets:
- Indication: Specifically designed for pediatric patients aged 2 to 5 years.
- Dosage:
- Children (2-5 years): Administer 1 tablet (4 mg) once daily in the evening.
- Administration:
- Take MYTEKA 4 mg tablets orally with or without food.
- Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet.
2. Montelukast Sodium 5 mg Tablets:
- Indication: Intended for pediatric patients aged 6 to 14 years.
- Dosage:
- Children (6-14 years): Administer 1 tablet (5 mg) once daily in the evening.
- Administration:
- Take MYTEKA 5 mg tablets orally with or without food.
- Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet.
3. Montelukast Sodium 10 mg Tablets:
- Indication: Formulated for adults and adolescents 15 years and older.
- Dosage:
- Adults and Adolescents (15+ years): Administer 1 tablet (10 mg) once daily in the evening.
- Administration:
- Take MYTEKA 10 mg tablets orally with or without food.
- Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet.
Frequency:
- Once Daily: Administer MYTEKA once daily, preferably in the evening, to maximize its preventive effects on nighttime asthma symptoms and overall respiratory health.
Duration of Treatment:
- Long-Term Therapy: MYTEKA is intended for long-term use in managing chronic conditions. Do not discontinue use without consulting your healthcare provider, even if you feel well.
Missed Dose:
- If you miss a dose, take it as soon as you remember.
- If it is near the time of your next dose, skip the missed dose and resume your regular dosing schedule.
- Do not take two doses at the same time to make up for a missed dose.
Precautions:
- Consult a Healthcare Provider: Always use MYTEKA under the supervision of a qualified healthcare professional to ensure appropriate treatment and to determine the correct dosage based on individual health conditions.
- Allergic Reactions: Discontinue use and seek immediate medical attention if you experience signs of an allergic reaction, such as rash, itching, swelling, severe dizziness, or difficulty breathing.
- Mental Health Considerations: Montelukast has been associated with mood changes and suicidal thoughts in some individuals. Monitor for any changes in mood or behavior and report them to your healthcare provider immediately.
- Liver Function: Inform your healthcare provider if you have a history of liver disease, as Montelukast is metabolized in the liver and may require dosage adjustments.
- Pregnancy and Breastfeeding: Consult your healthcare provider before using MYTEKA if you are pregnant, planning to become pregnant, or breastfeeding, as the medication may affect fetal development or pass into breast milk.
- Drug Interactions: Inform your healthcare provider about all other medications and supplements you are taking, as Montelukast may interact with other drugs that affect the central nervous system or respiratory system.
- Avoid Smoking: Smoking may exacerbate asthma symptoms and reduce the effectiveness of MYTEKA. Consider quitting smoking to enhance treatment outcomes.
- Kidney Function: Use with caution in individuals with impaired kidney function, as Montelukast is excreted primarily by the kidneys.
- Underlying Health Conditions: Inform your healthcare provider if you have other significant medical conditions, such as cardiovascular disease, to ensure safe and effective use of MYTEKA.
Possible Side Effects:
- Common Side Effects:
- Headache
- Dizziness
- Nausea
- Diarrhea
- Fatigue
- Upper respiratory tract infections
- Less Common Side Effects:
- Cough
- Sore throat
- Muscle pain
- Joint pain
- Serious Side Effects (Seek Medical Attention Immediately):
- Signs of severe allergic reaction, including rash, itching, swelling, severe dizziness, or difficulty breathing
- Mood changes, such as agitation, depression, or suicidal thoughts
- Seizures
- Severe abdominal pain
- Persistent vomiting
- Signs of liver dysfunction, such as yellowing of the skin or eyes (jaundice), dark urine, or persistent nausea and vomiting
Storage Instructions:
- Temperature: Store MYTEKA tablets at room temperature, between 15°C to 30°C (59°F to 86°F), away from direct sunlight and moisture to maintain their efficacy.
- Accessibility: Keep the medication out of reach of children to prevent accidental ingestion.
- Packaging Integrity: Ensure that blister packs or bottles are tightly sealed after each use to protect the tablets from environmental factors and maintain their shelf life.
- Expiration: Do not use the tablets beyond the expiration date indicated on the packaging. Discard any unused medication after this date.
- Proper Handling: Avoid contaminating the tablets by ensuring that hands are clean before handling and that the tablets are not exposed to moisture or other contaminants.